Cite
A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys.
MLA
Wentink, Madelon Q., et al. “A Safety and Immunogenicity Study of Immunization with HVEGF26-104/RFASE in Cynomolgus Monkeys.” Vaccine, vol. 36, no. 15, Apr. 2018, pp. 2025–32. EBSCOhost, https://doi.org/10.1016/j.vaccine.2018.02.066.
APA
Wentink, M. Q., Verheul, H. M. W., Griffioen, A. W., Schafer, K. A., McPherson, S., Early, R. J., van der Vliet, H. J., & de Gruijl, T. D. (2018). A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys. Vaccine, 36(15), 2025–2032. https://doi.org/10.1016/j.vaccine.2018.02.066
Chicago
Wentink, Madelon Q., Henk M.W. Verheul, Arjan W. Griffioen, Kenneth A. Schafer, Susan McPherson, Richard J. Early, Hans J. van der Vliet, and Tanja D. de Gruijl. 2018. “A Safety and Immunogenicity Study of Immunization with HVEGF26-104/RFASE in Cynomolgus Monkeys.” Vaccine 36 (15): 2025–32. doi:10.1016/j.vaccine.2018.02.066.